/

Chassis & Safety Systems

/

Granules Pharmaceuticals, Inc.

Granules Pharmaceuticals, Inc.

Granules Pharmaceuticals, Inc.

Verified Nov 2026

Chassis & Safety Systems

·

United States flag

Chantilly, Virginia

·

Since 2014

Granules Pharmaceuticals, Inc. is a U.S. subsidiary of Granules India Limited, headquartered in Chantilly, Virginia, and founded in 2014. The company employs 500–1,000 people and generates an estimated $100–250 million in annual revenue. It manufactures complex oral solid dosage forms including tablets, capsules, powders, and oral solutions for pharmaceutical clients. The firm received FDA Establishment Inspection Report clearance for its Chantilly facility in 2026 and holds DEA approval for controlled substance handling.

Granules Pharmaceuticals, Inc.

Verified Nov 2026

AT A GLANCE

Founded

2014

Headquarters

United States flag

Chantilly, Virginia

Employees

500-1,000

Ownership

Granules Pharmaceuticals, Inc. at a glance

Revenue

$100-250M

Est. band

Employees

500-1,000

Founded

2014

Headquarters

Chantilly, Virginia

Industries

Automotive

Electric Vehicles

Medical

Renewable Energy

Industrial Equipment

Overview

Granules Pharmaceuticals, Inc. is a U.S. subsidiary of Granules India Limited, headquartered in Chantilly, Virginia, and founded in 2014. The company employs 500–1,000 people and generates an estimated $100–250 million in annual revenue. It manufactures complex oral solid dosage forms including tablets, capsules, powders, and oral solutions for pharmaceutical clients. The firm received FDA Establishment Inspection Report clearance for its Chantilly facility in 2026 and holds DEA approval for controlled substance handling.

At a glance

Attribute

Detail

Founded

2014

Headquarters

Chantilly, Virginia

Employees

500-1,000

Revenue

$100-250M (estimated)

Primary capability

Chassis & Safety Systems

What Granules Pharmaceuticals, Inc. makes

The company operates over 100,000 square feet of manufacturing and R&D space and manufactures modified-release, immediate-release, and extended-release oral dosage forms compliant with Trade Agreements Act standards for U.S. government procurement.

Latest developments

Facilities

Granules Pharmaceuticals, Inc. is headquartered in Chantilly, Virginia. Public sources also reference these locations:

Company details

Granules India, the parent company, announced a $100 million five-year target for peptide contract development and manufacturing services expansion and is pursuing acquisitions to broaden its complex generics portfolio. Granules Pharmaceuticals, Inc. was founded in 2014, has an estimated 500-1,000 employees, and is headquartered in Chantilly, Virginia.

Frequently asked questions

What does Granules Pharmaceuticals, Inc. make?

Granules Pharmaceuticals, Inc. is a U.S. subsidiary of Granules India Limited, headquartered in Chantilly, Virginia, and founded in 2014. The company employs 500–1,000 people and generates an estimated $100–250 million in annual revenue. It manufactures complex oral solid dosage forms including tablets, capsules, powders, and oral solutions for pharmaceutical clients. The firm received FDA Establishment Inspection Report clearance for its Chantilly facility in 2026 and holds DEA approval for controlled substance handling.

Where is Granules Pharmaceuticals, Inc. headquartered?

Granules Pharmaceuticals, Inc. is headquartered in Chantilly, Virginia (3701 Concorde Pkwy, Chantilly, Virginia, 20151-1126).

When was Granules Pharmaceuticals, Inc. founded?

Granules Pharmaceuticals, Inc. was founded in 2014.

How big is Granules Pharmaceuticals, Inc.?

Granules Pharmaceuticals, Inc. has an estimated 500-1,000 employees, with revenue in the $100-250M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Chantilly, Virginia (HQ)Headquarters · United States
Chantilly, Virginia (HQ)3701 Concorde Pkwy, Chantilly, Virginia, 20151-1126, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.